Abstract
Testicular cancer usually occurs in young men, many of whom have not yet established a family at the time at which the diagnosis of cancer is made. Most of the tumors are germ cell tumors, which are highly curable with surgery, radiotherapy, chemotherapy, or multimodality treatment. The primary goal for urologists, radiotherapists, and medical oncologists is, of course, to cure the patient. Despite the obvious stress to the patient caused by the news of a diagnosis of testicular cancer, one must take time to discuss the fertility issues with the patient. Unlike Hodgkin’s disease, which also affects young men of reproductive age and is highly curable, testicular cancer involves an organ intrinsically linked with fertility, sexuality, and self-image (see Chap. 36). Rieker et al. (1990) showed that there were different fertility-related behaviors in these patients. Young childless patients without a stable relationship were more interested in sperm banking, while men who also lost their ejaculatory function after treatment had the greatest risk of continued distress regarding infertility. Rieker et al. showed that adjustment to infertility is a complex process that begins at diagnosis and extends long after treatment has been completed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aass N, Fossa SD, Theodorsen L, Norman N (1991) Prediction of long term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer 27: 1087–1091
Baniel J, Roth BJ, Foster RS, Donohue JP (1995) Cost and risk benefit in the management of clinical stage II non- seminomatous testicular tumors. Cancer 75: 2897–2903
Bar-Chama N, Herr HW, Sogani PC, et al. (1992) The fertility of males with stage I NSGCT managed on surveillance alone. J Urol 147: 337A
Bell IS, Alder EA (1994) Psychology of infertility and management. In: Hargreave TB (ed) Male infertility. Springer, London Berlin Heidelberg New York, pp 177–185
Berthelsen IG, Skakkebaek NE (1983) Gonadal function in men with testis cancer. Fértil Steril 39: 68–71
Brennemann W, Stoffel-Wagner B, Helmers A, Mezger I, läger N, Klingmüller D (1997) Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer. J Urol 158: 844–850
Carroll PR, Morse MI, Whitmore WF Ir, et al. (1987) Fertility status of patients with clinical stage I testis tumors on a surveillance protocol. J Urol 138: 70–72
Coogan CL, Hejase MI, Wahle GR, Foster RS, Rowland RG, Bihrle R, Donohue IP (1996) Nerve sparing post-chemotherapy retroperitoneal lymphnode dissection for advanced testicular cancer. I Urol 156: 1656–1658
Donohue IP, Foster RS, Rowland RG, Bihrle R, Iones I, Geier G (1990) Nerve–sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144: 287–290
Drasga RE, Einhorn LH, Williams SD, et al. (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1: 179–183
Ferreira U, Netto NR Ir, Esteves SC, Rivero MA, Schirren C (1991) Comparative study of the fertility potential of men with only one testicle. Scan I Urol Nephrol 25: 255–259
Fossa SD, Ous S, Abyholm T, et al. (1985) Post treatment fertility in patients with testicular cancer: influence of ret-roperitoneal lymph node dissection on ejaculatory potency. Br I Urol 57: 204–209
Fossa SD, Aass N, Molne K (1989a) Is routine pretreatment cryopreservation of semen worthwhile in the management of patients with testicular cancer? Br J Urol 64: 524–529
Fossa SD, Aass N, Kaalhus O (1989b) Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer. Cancer 64: 404
Fossa SD, Theodorsen L, Norman N, Aabyholm T (1990) Recovery of impaired pretreatment spermatogenesis in testicular cancer. Fértil Steril 54: 493–496
Foster RS, Rubin LR, McNulty A, et al. (1991) Detection of antisperm antibodies in patients with primary testicular cancer. Int] Androl 14: 179–182
Foster RS, McNulty A, Rubin LR, et al. (1994) The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection. I Urol 152: 1139–1143
Fritz K, Weissbach L (1985) Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer. Fértil Steril 43: 451–454
Garnick MB, Richie IP (1986) Toward more rational management for stage I testicular cancer. J Clin Oncol 4: 1021–1023
Giwercman A, von der Maase H, Berthelsen IG, Rorth M, Bertelsen A, Skakkebaek NE (1991) Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. I Clin Endocrinol Metab 73: 596–603
Hansen PV, Trykker H, Andersen I, Helkjaer PE (1989) Germ cell function and hormonal status in patients with testicu¬lar cancer. Cancer 64: 956–961
Hansen PV, Trykker H, Svennekjaer IL, Hvolby I (1990) Long-term recovery of spermatogenesis after radiotherapy in patients with testicular cancer. Radiat Oncol 18: 117–125
Hansen PV, Glavind K, Panduro J, Pedersen M (1991) Paternity in patients with testicular germ cell cancer: pretreatment and post-treatment findings. Eur J Cancer 27: 1385–1389
Hansen SW, Berthelsen JG, von der Maase H (1990) Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine and bleomycin versus surveillance. J Clin Oncol 8: 1695–1698
Höbarth K, Klingler HC, Maier U, Kollaritsch H (1994) Incidence of antisperm antibodies in patients with carcinoma of the testis and in subfertile men with normo-gonadotropic oligoasthenoteratozoospermia. Urol Int 52: 162–165
Horwich A, Nicholls EJ, Hendry WF (1988) Seminal analysis after orchiectomy in stage I teratoma. Br J Urol 62: 79
Jarow JP (1994) Life-threatening consitions associated with male infertility. Urol Clin North Am 21: 409–415
Jewett MAS, Thachill JV, Harris JF (1983) Exocrine function of testis with germinal testicular tumour. Br Med J 286:1849– 1851
Joos H, Chandra I, Frick J (1993) Endokrinologie und Fertilität beim Hodentumor im Stadium I. Helv Chir Acta 60:367– 370
Jorgensen N, Müller J, Giwercman A, Skakkebaek NE (1990) Clinical and biological significance of carcinoma in situ of the testis. Cancer Surv 9: 287–302
Kliesch S, Behre HM, Jürgens H, Nieschlag E (1996) Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol 26: 20–27
Kreuser ED, Klingmüller D, Thiel E (1993) The role of LHRH analogues in protecting gonadal functions during chemotherapy and irradiation. Eur Urol 23: 157–164
Lange PH, Chang WY, Fraley EE (1987) Fertility issues in the therapy in nonseminomatous testicular tumors. Urol Clin North Am 14: 731–747
Morrish DW, Venner PM, Siy O, Barrron G, Bhardway D, Outhet D (1990) Mechanisms of endocrine dysfunction in patients with testicular cancer. J Natl Cancer Inst 82:412– 418
Mortimer D (1994) Semen analysis and other standard laboratory tests. In: Hargreave TB (ed) Male infertility. Springer, London Berlin Heidelberg New York, pp 37–42
Mulvihill JJ, Meyers MH, Connelly R, et al. (1987) Cancer in offspring of long term survivors of childhood and adolescence cancer. Lancet 11: 813
Nijman JM, Schraffordt Koops H, Kremer J, et al. (1987) Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors. J Clin Oncol 5: 651
Ohl DA, Denil J, Bennet CJ, Randolph JF, Menge AC, McCabe M (1991) Electroejaculation following retroperitoneal lymphadenectomy. J Urol 145: 980–983
Oliver RTD, Oliver JC (1996) Endocrine hypothesis for declining sperm count and incidence of cancer. Lancet 347:339– 340
Palmieri G, Lotrecchiano G, Ricci G, Lombardi G, Bianco AR, Torino G (1996) Gonadal function after multimodality treatment in men with testicular germ cell cancer. Eur J Endocrinol 134: 431–436
Pont J, Albrecht W (1997) Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 68: 1–5
Presti JC, Herr HW, Carroll PR (1993) Fertility and testis cancer. Urol Clin North Am 20: 173–179
Rieker PP, Fitzgerald EM, Kalish LA (1990) Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8: 347–355
Rüssel LD, Rüssel JA (1991) Short–term morphological response of the rat testis to administration of five chemo– therapeutic agents. Am J Anat 192: 142–168
Sanger WG, Olson JH, Sherman JK (1992) Semen cryobanking for men with cancer-criteria change. Fertil Steril 58: 1024–1027
Senturia YD, Peckham CS (1990) Children fathered by men treated with chemotherapy for testicular cancer. Eur J Cancer 26: 429–432
Thachil JW, Jewett MAS, Rider WD (1981) The effects of cancer and cancer therapy on male fertility. J Urol 126:141– 145
Tournaye H, Camus M, Bollen N, Wisanto A, Van Steirteghem AC, Devroey P (1991) In vitro fertilization techniques with frozen-thawed sperm: a method for preserving the progenitive potential of Hodgkin patients. Fertil Steril 55: 443–445
Von der Maase H, Rorth M, Walbom-Jorgensen S, et al. (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. BMJ 293: 1398–1401
Wanderas EM, Fossa SD, Meilo A, et al. (1990) Serum follicle stimulating hormone: predictive of cancer in the remaining testes in patients with unilateral testicular cancer. Br J Urol 66: 315
Weissbach L, Boedefield EA, Oberdorster W (1985) Modified RLND as a means to preserve ejaculation. In: Khoury S, Kuss R, Murphy GP, et al. (eds) Testicular cancer. Liss, New York
Willemse PHB, Sleijfer D, Sluiter WI, et al. (1983) Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect. Acta Endocrinol 102: 616–619
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
De Ridder, D.J.M.K., Baert, L. (1999). Fertility Following Treatment of Testicular Carcinoma. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Kidney and Testis, and Rare Urologic Malignancies. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59839-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-59839-5_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64144-2
Online ISBN: 978-3-642-59839-5
eBook Packages: Springer Book Archive